MedTrace Logo

D-dimer Levels in Pregnant With COVID-19

NCT04389554 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-06-01

No results posted yet for this study

Summary

D-dimer measurements act as a global indicator of coagulation and activation of fibrinolytic systems. An optimal cut-off value for D-dimer and its effect on prognosis has not yet been assessed to predict mortality in admission. Therefore, studies comparing D-dimer values of COVID-19 patients and healthy pregnant women are needed. Our study gives us the opportunity to make this comparison.

Conditions

Interventions

OTHER

Blood D-dimer assay

Blood samples will be taken from the patients and will be examined by the ELISA method.

Sponsors & Collaborators

  • Kanuni Sultan Suleyman Training and Research Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-14
Primary Completion
2020-05-28
Completion
2020-05-29

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04389554 on ClinicalTrials.gov